Sowell Financial Services LLC Ionis Pharmaceuticals Inc Transaction History

Sowell Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$34.54 - $47.25 $36,577 - $50,037	-1,059 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$42.51 - $63.78 $977 - $1,466	23 Added 2.22%	1,059 $40,000
Q4 2020 Jan 13, 2021	SELL	$45.3 - $60.27 $69,309 - $92,213	-1,530 Reduced 59.63%	1,036 $59,000
Q3 2020 Nov 12, 2020	SELL	$47.45 - $62.95 $2,514 - $3,336	-53 Reduced 2.02%	2,566 $122,000
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $121,294 - $158,058	2,589 Added 8630.0%	2,619 $154,000
Q1 2020 May 12, 2020	SELL	$41.6 - $63.4 $6,905 - $10,524	-166 Reduced 84.69%	30 $1,000
Q4 2019 Feb 07, 2020	SELL	$53.85 - $65.27 $13,785 - $16,709	-256 Reduced 56.64%	196 $11,000
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $26,695 - $32,611	452 New	452 $27,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.